ScienceDex / Researcher record
Debora S Marks
- R01 Holder
- Early Career
NIH Funding · FY2024
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $1.7M in linked award amounts across 1 award record · Award-linked rank #7332.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10594039Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2024 award categories
- Biomedical Engineering
FY2024 award records by amount
NIH award records listing Debora S Marks as a PI. Multi-PI records show the full award amount for context.
- 5R01CA260415-05R01Co-investigatorMaking antibody generation rapid, scalable, and democratic through machine learning and continuous evolutionUniversity of California-Irvine · Biomedical Engineering (NIH department code)$1.7Maward amount
Award organization
Organizations that administered FY2024 awards listing Debora S Marks as a PI.
FY2024 award administered by University of California-Irvine (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California-Irvine
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7332
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Debora S Marks.